These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29045421)

  • 21. Cortical atrophy accelerates as cognitive decline worsens in multiple sclerosis.
    Eijlers AJC; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Pouwels PJW; Uitdehaag BMJ; Barkhof F; Vrenken H; Schoonheim MM; Geurts JJG
    Neurology; 2019 Oct; 93(14):e1348-e1359. PubMed ID: 31484713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
    Kearney H; Schneider T; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):608-14. PubMed ID: 25097217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical cord lesion load is associated with disability independently from atrophy in MS.
    Kearney H; Altmann DR; Samson RS; Yiannakas MC; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    Neurology; 2015 Jan; 84(4):367-73. PubMed ID: 25540312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low degree of cortical pathology is associated with benign course of multiple sclerosis.
    Calabrese M; Favaretto A; Poretto V; Romualdi C; Rinaldi F; Mattisi I; Morra A; Perini P; Gallo P
    Mult Scler; 2013 Jun; 19(7):904-11. PubMed ID: 23069877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
    Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
    J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis.
    Brettschneider J; Petzold A; Junker A; Tumani H
    Mult Scler; 2006 Apr; 12(2):143-8. PubMed ID: 16629417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
    Chu R; Tauhid S; Glanz BI; Healy BC; Kim G; Oommen VV; Khalid F; Neema M; Bakshi R
    J Neuroimaging; 2016; 26(1):62-7. PubMed ID: 26118637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI-detectable cortical lesions in the cerebellum and their clinical relevance in multiple sclerosis.
    Favaretto A; Lazzarotto A; Poggiali D; Rolma G; Causin F; Rinaldi F; Perini P; Gallo P
    Mult Scler; 2016 Apr; 22(4):494-501. PubMed ID: 26163070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis.
    Puthenparampil M; Federle L; Poggiali D; Miante S; Signori A; Pilotto E; Rinaldi F; Perini P; Sormani MP; Midena E; Gallo P
    PLoS One; 2017; 12(8):e0183957. PubMed ID: 28850630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.
    Calabrese M; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Romualdi C; Rinaldi L; Perini P; Gallo P
    Neurology; 2010 Jan; 74(4):321-8. PubMed ID: 20101038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normalized regional brain atrophy measurements in multiple sclerosis.
    Zivadinov R; Locatelli L; Stival B; Bratina A; Grop A; Nasuelli D; Brnabic-Razmilic O; Zorzon M
    Neuroradiology; 2003 Nov; 45(11):793-8. PubMed ID: 14551760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choroid Plexus Enlargement in Inflammatory Multiple Sclerosis: 3.0-T MRI and Translocator Protein PET Evaluation.
    Ricigliano VAG; Morena E; Colombi A; Tonietto M; Hamzaoui M; Poirion E; Bottlaender M; Gervais P; Louapre C; Bodini B; Stankoff B
    Radiology; 2021 Oct; 301(1):166-177. PubMed ID: 34254858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thalamic involvement in multiple sclerosis: a diffusion-weighted magnetic resonance imaging study.
    Fabiano AJ; Sharma J; Weinstock-Guttman B; Munschauer FE; Benedict RH; Zivadinov R; Bakshi R
    J Neuroimaging; 2003 Oct; 13(4):307-14. PubMed ID: 14569822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
    Dackovic J; Pekmezovic T; Mesaros S; Dujmovic I; Stojsavljevic N; Martinovic V; Drulovic J
    Neurol Sci; 2016 Sep; 37(9):1475-81. PubMed ID: 27207679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis.
    Harrison DM; Roy S; Oh J; Izbudak I; Pham D; Courtney S; Caffo B; Jones CK; van Zijl P; Calabresi PA
    JAMA Neurol; 2015 Sep; 72(9):1004-12. PubMed ID: 26192316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrophy and structural variability of the upper cervical cord in early multiple sclerosis.
    Biberacher V; Boucard CC; Schmidt P; Engl C; Buck D; Berthele A; Hoshi MM; Zimmer C; Hemmer B; Mühlau M
    Mult Scler; 2015 Jun; 21(7):875-84. PubMed ID: 25139943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications.
    Fox RJ; Fisher E; Tkach J; Lee JC; Cohen JA; Rudick RA
    Mult Scler; 2005 Apr; 11(2):140-5. PubMed ID: 15794385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.